PRKAA2 mediates the pathogenesis of metabolic dysfunction-associated steatotic liver disease via PI3K/AKT signaling pathway

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most prevalent type of chronic liver disease, posing a significant threat to human health. Protein kinase AMP-activated catalytic subunit alpha 2 (PRKAA2) plays a pivotal role in regulating metabo...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jiayi Li, Guiling Wu, Zihao Li, Xinghuan Liang, Yiyu Chen, Bing Yang, Jing Xian, Tingting Deng, Cuihong Chen, Li Li, Yang Liu, Tian Xiong, Sihui Wu, Xi Yang, Yingfen Qin
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2025-11-01
Serija:	Human Genomics
Teme:	PRKAA2 Signaling pathway miRNA MASLD Pathogenesis
Online dostop:	https://doi.org/10.1186/s40246-025-00854-2
Oznake:	Označite Brez oznak, prvi označite!